Pular para o conteúdo principal
Ranking Invest

ARAY - Accuray Incorporated

Segmento: HealthcareAccuray Incorporated designs, develops, manufactures, and sells radiosurgery and radiation therapy systems for the treatment of tumors in the United States, Canada, Latin America, Australia, New Zealand, Europe, the Middle East, India, Africa, Japan, China, and rest of the Asia Pacific region. It offers the CyberKnife System, a robotic stereotactic radiosurgery and stereotactic body radiation therapy system used for the treatment of primary and metastatic tumors outside the brain, including tumors on or near the spine and in the breast, kidney, liver, lung, pancreas, and prostate. The company also provides the TomoTherapy System, including the Radixact System, which allows for integrated radiation treatment planning, delivery, and data management, enabling clinicians to deliver ultra-precise treatments to approximately 50 patients per day; iDMS data management system, a fully integrated treatment planning and data management systems; and Accuray precision treatment planning system, a treatment planning and data management systems. In addition, it offers post-contract customer support, installation, training, and other professional services. The company primarily markets its products directly to customers, including hospitals and stand-alone treatment facilities through its sales organization, as well as to customers through sales agents and group purchasing organizations in the United States; and to customers directly and through distributors and sales agents internationally. Accuray Incorporated was incorporated in 1990 and is headquartered in Madison, Wisconsin.

Análise Ranking Invest

Valor de Mercado
$ 15.69 Mi
IVR
-2.54Índice proprietário de comparação relativa: -2,54.
IVR2
-4.51Leitura proprietária complementar: -451%.
MLL
-4.51Leitura proprietária complementar: -451%.
Último Balanço Atualizado: 4T2026

O Ranking Invest utiliza metodologia proprietária baseada em dados financeiros públicos; fórmulas e valores intermediários são confidenciais.

Dados da Empresa

Patrimônio Líquido

$ 41.70 Mi

Dívida Líquida

$ 107.25 Mi

L4T

-$ 49.19 Mi

MM4T

-12.43%

Indicadores Básicos

ROE

-117.97%

Índices de Previsibilidade

Receita Líquida

D0.08

Lucro

E1.06

Margem

D1.06

Índices de Tendência

Receita Líquida

D-1.85

Lucro

E-4.01

Margem

E-4.09

Índices de Endividamento

DIV/PAT

2.57

DIV/L4T

-2.18

Dívidas
Cotação
Gráfico Lucro/Receita Líquida X TrimestrePor padrão são exibidos os últimos 16 trimestres; quando houver mais trimestres disponíveis, use o botão junto à tabela de resultados para expandir o histórico.